Psoriasis News and Research RSS Feed - Psoriasis News and Research

Psoriasis is a chronic, immune-mediated disease that results from the overproduction of skin cells, resulting in their accumulation on the surface of the skin, which causes red, scaly plaques that may itch and bleed. It is estimated that approximately 7.5 million Americans and nearly 3 percent of the world's population are living with psoriasis and nearly one-quarter of those people have cases that are considered moderate to severe.
New insights into epidermal cells could explain how skin maintains barrier when shedding

New insights into epidermal cells could explain how skin maintains barrier when shedding

The discovery of the shape and binding capability of epidermal cells could explain how skin maintains a barrier even when it is shedding. [More]
Study shows new drug combination effective in treating precancerous skin lesions

Study shows new drug combination effective in treating precancerous skin lesions

A combination of two topical drugs that have been in use for years triggers a robust immune response against precancerous skin lesions, according to a new study. The research, from Washington University School of Medicine in St. Louis and Harvard Medical School, shows that the therapy activates the immune system's T cells, which then attack the abnormal skin cells. [More]
Psoriatic arthritis patients experience multiple symptoms that can make diagnosis difficult, survey reveals

Psoriatic arthritis patients experience multiple symptoms that can make diagnosis difficult, survey reveals

Psoriatic arthritis (PsA) is an inflammatory condition closely related to and most often co-occurring with psoriasis. [More]
Common bacteria on human skin may offer protection against diseases

Common bacteria on human skin may offer protection against diseases

There are more and more examples of the ways in which we can benefit from our bacteria. According to researcher Rolf Lood from Lund University in Sweden, this is true for the skin as well. [More]
Scientists develop new strategy to stop uncontrollable poison ivy itch

Scientists develop new strategy to stop uncontrollable poison ivy itch

Scientists at Duke Health and Zhejiang Chinese Medical University have developed a strategy to stop the uncontrollable itch caused by urushiol, the oily sap common to poison ivy, poison sumac, poison oak and even mango trees. [More]
FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis. [More]
Almirall launches ‘Not Today’ story to raise awareness about psoriasis

Almirall launches ‘Not Today’ story to raise awareness about psoriasis

In the framework of the World Psoriasis Day, which this year’s theme is “Breaking Barriers”, the International Federation of Psoriasis Association (IFPA) aims to raise awareness, fight prejudices and gain access to proper diagnosis for people with psoriasis. [More]
Novel approach may speed up development of new drugs against skin disease

Novel approach may speed up development of new drugs against skin disease

In an ideal world, the newest and most effective drugs for chronic inflammatory conditions would immediately help everyone who took them. [More]
Dermatologist shares tips to keep skin in good shape during winter

Dermatologist shares tips to keep skin in good shape during winter

The dreary British weather can play havoc with our skin, especially for those with existing skin conditions like eczema or psoriasis. [More]
Anti-inflammatory drugs may improve severity of depressive symptoms, study finds

Anti-inflammatory drugs may improve severity of depressive symptoms, study finds

Anti-inflammatory drugs similar to those used to treat conditions such as rheumatoid arthritis and psoriasis could in future be used to treat some cases of depression, concludes a review led by the University of Cambridge, which further implicates our immune system in mental health disorders. [More]
Discovery of neuropilin 2 deficiency may lead to new therapies for edema and lymphedema

Discovery of neuropilin 2 deficiency may lead to new therapies for edema and lymphedema

Fluid accumulation and swelling (edema) may result from the malfunctioning of regulatory processes controlling vessel permeability in the body. [More]
New study finds no evidence of benefit from genetic disposition of eczema

New study finds no evidence of benefit from genetic disposition of eczema

Some genetic diseases persist for generation after generation because the genes that cause them can benefit human health. [More]
Novartis presents new findings from global psoriasis survey at EADV Congress

Novartis presents new findings from global psoriasis survey at EADV Congress

Novartis presented new findings from the largest global survey to date of people with psoriasis, showing many do not achieve the treatment goal of clear skin or even believe it is a realistic goal. [More]

Internet-based cognitive behavioral therapy may benefit psoriasis patients

A randomized controlled trial published in the current issue of Psychotherapy and Psychosomatics outlines new prospects for the treatment of psoriasis. [More]

IFPA, ILDS and IPC launch first-ever global epidemiological psoriasis database

Today’s Global Psoriasis Atlas (GPA) launch will create the first-ever, comprehensive global database on psoriasis. It responds to an urgent World Health Organization call to fill global knowledge gaps on the incidence and prevalence of this serious non-communicable disease. [More]
FDA approves new biosimilar for multiple inflammatory diseases

FDA approves new biosimilar for multiple inflammatory diseases

The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases. [More]
Skin phenotype of pediatric eczema opens door for personalized treatment of AD in infants

Skin phenotype of pediatric eczema opens door for personalized treatment of AD in infants

Researchers for the first time have identified the skin phenotype of pediatric eczema or atopic dermatitis (AD) in infants, opening the door for personalized treatment approaches for young children with eczema. [More]
TSRI scientists shed light on molecular workings of MS drug

TSRI scientists shed light on molecular workings of MS drug

A study by scientists at The Scripps Research Institute has helped to de-mystify the molecular workings of the multiple sclerosis (MS) drug Tecfidera. The drug is the most widely prescribed pill-based therapy for MS, but its biological mechanism remains mysterious. [More]
Food intolerance testing: an interview with Dr Gill Hart

Food intolerance testing: an interview with Dr Gill Hart

Food intolerances are caused by adverse reactions to food or drink ingredients in your body. These are very different to food allergies. It is estimated that up to forty-five percent of the population suffers from food intolerances. [More]
Could a light-listening photonics device detect skin disease? An interview with Prof. Vasilis Ntziachristos

Could a light-listening photonics device detect skin disease? An interview with Prof. Vasilis Ntziachristos

Detection of malignant skin alterations is currently aided by optical microscopes such as dermoscopes or optical microscopes. While the latter offers high resolution, it comes with a major disadvantage, just like any other purely microscopic method: it only provides a partial view of the skin due to the low penetration depth. [More]
Advertisement